Evidence map›Paper›PMID 32703934›Full record

ArticleCell death & disease2020

Deficiency of microRNA-628-5p promotes the progression of gastric cancer by upregulating PIN1.

Yang Chen, Yaran Wu, Shuhui Yu, Hongying Yang, Xiya Wang, Yali Zhang, Shunqin Zhu, Mengmeng Jie, Cheng Liu, Xinzhe Li and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Yang Chen *School of Life Science, Southwest University. No. 1, Tiansheng RD, Beibei District, Chongqing, 400715, China.
Yaran Wu *Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University. No. 183, Xinqiao Main ST, Shapingba District, Chongqing, 400037, China.
Shuhui YuSchool of Life Science, Southwest University. No. 1, Tiansheng RD, Beibei District, Chongqing, 400715, China.
Hongying YangSchool of Life Science, Southwest University. No. 1, Tiansheng RD, Beibei District, Chongqing, 400715, China.
Xiya WangSchool of Life Science, Southwest University. No. 1, Tiansheng RD, Beibei District, Chongqing, 400715, China.
Yali ZhangDepartment of Hematology, Southwest Hospital, Third Military Medical University. No. 30, Gaotanyan Main ST, Shapingba District, Chongqing, 400038, China.
Shunqin ZhuSchool of Life Science, Southwest University. No. 1, Tiansheng RD, Beibei District, Chongqing, 400715, China.
Mengmeng JieDepartment of Gastroenterology, Xinqiao Hospital, Third Military Medical University. No. 183, Xinqiao Main ST, Shapingba District, Chongqing, 400037, China.
Cheng LiuDepartment of Gastroenterology, Xinqiao Hospital, Third Military Medical University. No. 183, Xinqiao Main ST, Shapingba District, Chongqing, 400037, China.
Xinzhe LiDepartment of Gastroenterology, Xinqiao Hospital, Third Military Medical University. No. 183, Xinqiao Main ST, Shapingba District, Chongqing, 400037, China.
You ZhouCollege of Biotechnology, Southwest University. No. 1, Tiansheng RD, Beibei District, Chongqing, 400715, China.
Shiming YangDepartment of Gastroenterology, Xinqiao Hospital, Third Military Medical University. No. 183, Xinqiao Main ST, Shapingba District, Chongqing, 400037, China.
Yingbin YangSchool of Life Science, Southwest University. No. 1, Tiansheng RD, Beibei District, Chongqing, 400715, China. yybin@swu.edu.cn.
Southwest University · CNArmy Medical University · CNXinqiao Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer is one of the most common cancer and is the second leading cause of cancer-related mortality in the world. PIN1, belonging to peptidyl-prolyl cis-trans isomerase family, uniquely catalyzes the structural transformation of phosphorylated Ser/Thr-Pro motif. It's high expressed in most cancers and promotes their progression. However, the mechanism of PIN1 high expression and its function in gastric cancer progression are still unclear. In this research, we revealed that PIN1 not only promotes the proliferation and colony formation of gastric cancer, but also increases its migration and invasion. The PIN1 expression in metastasis lesion is usually higher than the corresponding primary site. Inhibiting PIN1 by shRNA suppresses the progression of gastric cancer significantly. Besides, we demonstrated that miR-628-5p is a novel PIN1-targeted microRNA, and the expression of miR-628-5p is negatively correlated with PIN1 in gastric cancer. Exogenous expression of miR-628-5p inhibits the progression of gastric cancer that revered by restoring PIN1 expression. However, miR-628-5p is downregulated in majority of gastric cancer tissue especially in metastasis lesion. The lower miR-628-5p level indicates poorer prognosis. In summary, our study demonstrated that deficient miR-628-5p expression facilitates the expression of PIN1, and consequently promotes the progression of gastric cancer.

Indexed as

Disease ProgressionGene Expression Regulation, Neoplastic3' Untranslated RegionsBase SequenceCell Line, TumorDown-RegulationHumansMicroRNAsNeoplasm MetastasisNIMA-Interacting Peptidylprolyl IsomerasePrognosisRNA, MessengerStomach NeoplasmsUp-Regulation3' Untranslated RegionsMicroRNAsMIRN628 microRNA, humanNIMA-Interacting Peptidylprolyl IsomerasePIN1 protein, humanRNA, Messenger

Identifiers

PMID32703934
PMCPMC7378826
OpenAlexW3044706605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.